Autism Spectrum Disorder (ASD) is associated with persistent impairments in adaptive abilities across multiple domains. These social, personal, and communicative impairments become increasingly pronounced with development, and are present regardless of IQ. The Vineland Adaptive Behavior Scales, Second Edition (Vineland-II) is the most commonly used instrument for quantifying these impairments, but minimal clinically important differences (MCIDs) on Vineland-II scores have not been rigorously established in ASD. We pooled data from several consortia/registries (EU-AIMS LEAP study, ABIDE-I, ABIDE-II, INFOR, Simons Simplex Collection and Autism Treatment Network [ATN]) and clinical investigations and trials (Stanford, Yale, Roche) resulting in a data set of over 9,000 individuals with ASD. Two approaches were used to estimate MCIDs: distribution-based methods and anchor-based methods. Distribution-based MCID [d-MCID] estimates included the standard error of the measurement, as well as one-fifth and one-half of the covariate-adjusted standard deviation (both cross-sectionally and longitudinally). Anchor-based MCID [a-MCID] estimates include the slope of linear regression of clinician ratings of severity on the Vineland-II score, the slope of linear regression of clinician ratings of longitudinal improvement category on Vineland-II change, the Vineland-II change score maximally differentiating clinical impressions of minimal versus no improvement, and equipercentile equating. Across strata, the Vineland-II Adaptive Behavior Composite standardized score MCID estimates range from 2.01 to 3.2 for distribution-based methods, and from 2.42 to 3.75 for sample-size-weighted anchor-based methods. Lower Vineland-II standardized score MCID estimates were observed for younger and more cognitively impaired populations. These MCID estimates enable users of Vineland-II to assess both the statistical and clinical significance of any observed change. Autism Res 2018, 11: 270-283.
Autism Spectrum Disorder (ASD) is associated with persistent impairments in adaptive abilities across multiple domains. These social, personal, and communicative impairments become increasingly pronounced with development, and are present regardless of IQ. The Vineland Adaptive Behavior Scales, Second Edition (Vineland-II) is the most commonly used instrument for quantifying these impairments, but minimal clinically important differences (MCIDs) on Vineland-II scores have not been rigorously established in ASD. We pooled data from several consortia/registries (EU-AIMS LEAP study, ABIDE-I, ABIDE-II, INFOR, Simons Simplex Collection and Autism Treatment Network [ATN]) and clinical investigations and trials (Stanford, Yale, Roche) resulting in a data set of over 9,000 individuals with ASD. Two approaches were used to estimate MCIDs: distribution-based methods and anchor-based methods. Distribution-based MCID [d-MCID] estimates included the standard error of the measurement, as well as one-fifth and one-half of the covariate-adjusted standard deviation (both cross-sectionally and longitudinally). Anchor-based MCID [a-MCID] estimates include the slope of linear regression of clinician ratings of severity on the Vineland-II score, the slope of linear regression of clinician ratings of longitudinal improvement category on Vineland-II change, the Vineland-II change score maximally differentiating clinical impressions of minimal versus no improvement, and equipercentile equating. Across strata, the Vineland-II Adaptive Behavior Composite standardized score MCID estimates range from 2.01 to 3.2 for distribution-based methods, and from 2.42 to 3.75 for sample-size-weighted anchor-based methods. Lower Vineland-II standardized score MCID estimates were observed for younger and more cognitively impaired populations. These MCID estimates enable users of Vineland-II to assess both the statistical and clinical significance of any observed change. Autism Res 2018, 11: 270-283.
Authors: G S Fisch; R Simensen; J Tarleton; M Chalifoux; J J Holden; N Carpenter; P N Howard-Peebles; A Maddalena Journal: Am J Med Genet Date: 1996-08-09
Authors: Helen McConachie; Jeremy R Parr; Magdalena Glod; Jennifer Hanratty; Nuala Livingstone; Inalegwu P Oono; Shannon Robalino; Gillian Baird; Bryony Beresford; Tony Charman; Deborah Garland; Jonathan Green; Paul Gringras; Glenys Jones; James Law; Ann S Le Couteur; Geraldine Macdonald; Elaine M McColl; Christopher Morris; Jacqueline Rodgers; Emily Simonoff; Caroline B Terwee; Katrina Williams Journal: Health Technol Assess Date: 2015-06 Impact factor: 4.014
Authors: Peter Szatmari; Stelios Georgiades; Eric Duku; Teresa A Bennett; Susan Bryson; Eric Fombonne; Pat Mirenda; Wendy Roberts; Isabel M Smith; Tracy Vaillancourt; Joanne Volden; Charlotte Waddell; Lonnie Zwaigenbaum; Mayada Elsabbagh; Ann Thompson Journal: JAMA Psychiatry Date: 2015-03 Impact factor: 21.596
Authors: Andre F Marquand; Thomas Wolfers; Maarten Mennes; Jan Buitelaar; Christian F Beckmann Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2016-09
Authors: Brittany R Howell; Martin A Styner; Wei Gao; Pew-Thian Yap; Li Wang; Kristine Baluyot; Essa Yacoub; Geng Chen; Taylor Potts; Andrew Salzwedel; Gang Li; John H Gilmore; Joseph Piven; J Keith Smith; Dinggang Shen; Kamil Ugurbil; Hongtu Zhu; Weili Lin; Jed T Elison Journal: Neuroimage Date: 2018-03-22 Impact factor: 6.556
Authors: A Stewart Campbell; Brittany D Needham; Christopher R Meyer; Joanna Tan; Mary Conrad; Gregory M Preston; Federico Bolognani; Srinivas G Rao; Helen Heussler; Rebecca Griffith; Adam J Guastella; Amy C Janes; Blaise Frederick; David H Donabedian; Sarkis K Mazmanian Journal: Nat Med Date: 2022-02-14 Impact factor: 53.440
Authors: S Fried; M Gafner; D Jeddah; N Gosher; D Hoffman; R Ber; A Mayer; E Katorza Journal: AJNR Am J Neuroradiol Date: 2021-08-12 Impact factor: 4.966
Authors: Kristen R Choi; Bhumi Bhakta; Elizabeth A Knight; Tracy A Becerra-Culqui; Teri L Gahre; Bonnie Zima; Karen J Coleman Journal: J Dev Behav Pediatr Date: 2022-01-01 Impact factor: 2.225
Authors: Sergio Serrada-Tejeda; Sergio Santos-Del-Riego; Teresa A May-Benson; Marta Pérez-de-Heredia-Torres Journal: Int J Environ Res Public Health Date: 2021-05-26 Impact factor: 3.390
Authors: Laura Gisbert-Gustemps; Jorge Lugo-Marín; Imanol Setien Ramos; Gemma Español Martín; Eduard Vieta; C Mar Bonnín; Josep Antoni Ramos Quiroga Journal: BMC Psychiatry Date: 2021-06-29 Impact factor: 3.630